Top Markets
#1 GALA GALA +32.99%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.54%
#3 Fabric Protocol Fabric Protocol +32.24%
#4 Audiera Audiera +32.22%
#5 Bitcoin Cash Bitcoin Cash +31.91%
#6 Tutorial Tutorial +30.33%
#7 Zora Zora +29.59%
#8 Bless Bless +29.29%
#9 Arowana Arowana +28.17%
#10 TROLL TROLL +27.25%
Coin of the day
GALA GALA
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Rang in aandelen #24577
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Aandeelprijs
$1.48
Laatst gesynchroniseerd: 2025-03-24
Marktkapitalisatie
$59.05M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
GB
Handel Achilles Therapeutics plc (ACHL)

Categorie

Healthcare
P/B-ratio voor Achilles Therapeutics plc (ACHL)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Achilles Therapeutics plc is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor Achilles Therapeutics plc van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH